HRMY Earnings Date: Nov 4, 2026 (Estimated) — Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is HRMY's next earnings date?
Harmony Biosciences Holdings, Inc. (HRMY) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.09 on revenue of $272.1M.
How did HRMY do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), Harmony Biosciences Holdings, Inc. posted EPS of $1.28 versus the $0.96 estimate, a beat of 21.9%. Revenue was $261.3M against a $250.8M estimate. The stock's 1-day post-earnings move was +8.9%.
How much does HRMY stock move after earnings?
HRMY beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.9% (up or down) in the day after earnings.
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | 0.96 | 1.28 | +21.90% | $261.3M | ✅ Beat | +8.93% | +9.55% | +15.87% |
| 2026-05-07 | Q1 2026 | 0.90 | 0.55 | -38.89% | $215.4M | ❌ Miss | -4.15% | -5.95% | -1.77% |
| 2026-02-24 | Q4 2025 | 0.98 | 0.57 | -41.84% | $243.8M | ❌ Miss | +4.91% | +7.55% | +0.86% |
| 2025-11-04 | Q3 2025 | 0.88 | 1.08 | +22.73% | $239.5M | ✅ Beat | +4.74% | +8.49% | +26.15% |
| 2025-08-05 | Q2 2025 | 0.89 | 0.92 | +3.37% | $200.5M | ✅ Beat | -1.69% | -2.08% | +5.60% |
| 2025-02-25 | Q4 2024 | 0.82 | 1.08 | +31.71% | $201.3M | ✅ Beat | +8.16% | -5.85% | -3.48% |
| 2024-10-29 | Q3 2024 | 0.66 | 1.03 | +56.06% | $186.0M | ✅ Beat | +16.06% | -7.55% | -2.57% |
| 2024-08-06 | Q2 2024 | -0.06 | 1.05 | +1850.00% | $172.8M | ✅ Beat | +6.18% | +8.05% | +16.56% |
Showing last 8 quarters.